Black Hawk Acquisition Corp. to Acquire 03 Life Sciences

Ticker: BKHAR · Form: 8-K · Filed: Jun 24, 2025 · CIK: 2000775

Black Hawk Acquisition CORP 8-K Filing Summary
FieldDetail
CompanyBlack Hawk Acquisition CORP (BKHAR)
Form Type8-K
Filed DateJun 24, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: acquisition, biotech, spac

Related Tickers: BKHAU

TL;DR

BHAC is buying 03 Life Sciences, moving into biotech.

AI Summary

Black Hawk Acquisition Corp. announced on June 23, 2025, that it has entered into a definitive agreement to acquire 03 Life Sciences, a company specializing in biological products. The filing does not disclose the financial terms of the acquisition.

Why It Matters

This acquisition signals Black Hawk Acquisition Corp.'s strategic move into the biological products sector, potentially diversifying its portfolio and market focus.

Risk Assessment

Risk Level: medium — Acquisitions inherently carry risks related to integration, valuation, and market reception, especially for SPACs targeting specific industries.

Key Players & Entities

FAQ

What is the nature of 03 Life Sciences' business?

03 Life Sciences is involved in biological products, as indicated by Black Hawk Acquisition Corp.'s SIC code.

What is the jurisdiction of incorporation for Black Hawk Acquisition Corp.?

Black Hawk Acquisition Corp. is incorporated in the Cayman Islands.

What is the principal business address of Black Hawk Acquisition Corp.?

The principal business address is 4125 Blackhawk Plaza Circle, Suite 166, Danville, CA 94506.

What is the filing date of this 8-K report?

The filing date is June 24, 2025.

What is the SIC code for Black Hawk Acquisition Corp.'s industry?

The Standard Industrial Classification (SIC) code is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding Black Hawk Acquisition Corp (BKHAR).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing